Alpha Cognition (ACOG) Competitors

Alpha Cognition (NASDAQ:ACOG) and Iovance Biotherapeutics (NASDAQ:IOVA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

Which has preferable valuation and earnings, ACOG or IOVA?

Alpha Cognition has higher earnings, but lower revenue than Iovance Biotherapeutics. Alpha Cognition is trading at a lower price-to-earnings ratio than Iovance Biotherapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	N/A	N/A	-$14.64M	-$1.20	-8.31
Iovance Biotherapeutics	$212.68M	4.91	-$372.18M	-$1.24	-2.52

Which has more volatility & risk, ACOG or IOVA?

Alpha Cognition has a beta of 2.73, meaning that its share price is 173% more volatile than the S&P 500. Comparatively, Iovance Biotherapeutics has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500.

Do analysts prefer ACOG or IOVA?

Alpha Cognition presently has a consensus price target of $20.00, indicating a potential upside of 100.60%. Iovance Biotherapeutics has a consensus price target of $12.22, indicating a potential upside of 290.49%. Given Iovance Biotherapeutics' higher possible upside, analysts plainly believe Iovance Biotherapeutics is more favorable than Alpha Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Iovance Biotherapeutics	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.33

Is ACOG or IOVA more profitable?

Alpha Cognition has a net margin of 0.00% compared to Iovance Biotherapeutics' net margin of -176.49%. Iovance Biotherapeutics' return on equity of -49.71% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	N/A	-65.83%	-48.21%
Iovance Biotherapeutics	-176.49%	-49.71%	-39.18%

Do insiders & institutionals believe in ACOG or IOVA?

77.0% of Iovance Biotherapeutics shares are held by institutional investors. 14.0% of Alpha Cognition shares are held by company insiders. Comparatively, 10.3% of Iovance Biotherapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Does the media refer more to ACOG or IOVA?

In the previous week, Iovance Biotherapeutics had 18 more articles in the media than Alpha Cognition. MarketBeat recorded 19 mentions for Iovance Biotherapeutics and 1 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 1.87 beat Iovance Biotherapeutics' score of 0.14 indicating that Alpha Cognition is being referred to more favorably in the media.

Company	Overall Sentiment
Alpha Cognition	Very Positive
Iovance Biotherapeutics	Neutral

Summary

Iovance Biotherapeutics beats Alpha Cognition on 8 of the 15 factors compared between the two stocks.